Jennifer Ann Nelsen, in Mason City, IA - Medicare Nurse Practitioner

Jennifer Ann Nelsen, is a medicare enrolled "Nurse Practitioner - Psychiatric/mental Health" in Mason City, Iowa. Her current practice location is 14259 300th St, Mason City, Iowa. You can reach out to her office (for appointments etc.) via phone at (641) 420-1277.

Jennifer Ann Nelsen is licensed to practice in Iowa (license number G173730) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1053098285.

Contact Information

	Jennifer Ann Nelsen,
	14259 300th St, Mason City, IA 50401-9437
	(641) 420-1277
	Not Available

Provider's Profile

Full Name	Jennifer Ann Nelsen
Gender	Female
Speciality	Nurse Practitioner - Psychiatric/mental Health
Location	14259 300th St, Mason City, Iowa
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1053098285
Provider Enumeration Date: 06/29/2023
Last Update Date: 06/29/2023

Medicare PECOS Information:

PECOS PAC ID: 5698138972
Enrollment ID: I20230905001172

Medical Identifiers

Medical identifiers for Jennifer Ann Nelsen such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053098285	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363LP0808X	Nurse Practitioner - Psychiatric/mental Health	G173730 (Iowa)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jennifer Ann Nelsen allows following entities to bill medicare on her behalf.

Entity Name	Ottumwa Health Group Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1386956290 PECOS PAC ID: 3971629924 Enrollment ID: O20100927001257

News Archive

Entry inhibitors can provide first new hepatitis B & D treatments for many years

Promising new viral hepatitis data presented today at the International Liver CongressTM show that entry inhibitors -a new mechanism of action for drugs to treat viral hepatitis - could provide the first new hepatitis B and hepatitis D treatments for many years.

Younger, older patients report more pain and less activity following total knee replacement surgery

While all age groups report comparable improvement in range of motion following total knee replacement surgery (TKR), new research presented today at the 2016 Annual Meeting of the American Academy of Orthopaedic Surgeons found that patients age 45 and younger, and those age 75 and older, report more pain and less activity following the procedure.

Automated patient registration process reduces waiting times, routine administrative tasks

Orlando Internal Medicine, an eight-provider practice, is expediting the collection of patient co-payments, deductibles and payer reimbursement through its use of self-service solutions from Greatwater Software and NCR Corporation/

Boehringer Ingelheim begins SENSCIS study to investigate safety, efficacy of nintedanib in patients with SSc-ILD

Boehringer Ingelheim announced today that the first person has been enrolled in the SENSCIS (Safety and Efficacy ofNintedanib in Systemic SClerosIS) study.

Sunitinib may be associated with cardiac toxicity

Another FDA-approved targeted cancer drug, sunitinib (SutentTM, Pfizer), may be associated with cardiac toxicity, report researchers at Children's Hospital Boston, Dana-Farber Cancer Institute (Boston), and Thomas Jefferson University (Philadelphia).

Entity Name	Forefront Telecare Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1174035612 PECOS PAC ID: 9638319114 Enrollment ID: O20190821004732

Entry inhibitors can provide first new hepatitis B & D treatments for many years

Younger, older patients report more pain and less activity following total knee replacement surgery

Automated patient registration process reduces waiting times, routine administrative tasks

Boehringer Ingelheim begins SENSCIS study to investigate safety, efficacy of nintedanib in patients with SSc-ILD

Boehringer Ingelheim announced today that the first person has been enrolled in the SENSCIS (Safety and Efficacy ofNintedanib in Systemic SClerosIS) study.

Sunitinib may be associated with cardiac toxicity

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jennifer Ann Nelsen is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jennifer Ann Nelsen, 14259 300th St, Mason City, IA 50401-9437 Ph: (641) 420-1277	Jennifer Ann Nelsen, 14259 300th St, Mason City, IA 50401-9437 Ph: (641) 420-1277

News Archive

Entry inhibitors can provide first new hepatitis B & D treatments for many years

Younger, older patients report more pain and less activity following total knee replacement surgery

Automated patient registration process reduces waiting times, routine administrative tasks

Boehringer Ingelheim begins SENSCIS study to investigate safety, efficacy of nintedanib in patients with SSc-ILD

Boehringer Ingelheim announced today that the first person has been enrolled in the SENSCIS (Safety and Efficacy ofNintedanib in Systemic SClerosIS) study.

Sunitinib may be associated with cardiac toxicity

Nurse Practitioner Nurses in Mason City, IA

Carrie Potter, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 910 N Eisenhower Ave, Mason City, IA 50401 Phone: 641-428-7000
Victoria Lee Stromer, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1631 4th St Sw, Mason City, IA 50401 Phone: 641-428-6000 Fax: 641-428-6007
Ashley Matern, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-6999 Fax: 641-428-6678
Trisha Lynn Tibbitts, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1631 4th St Sw # 114b, Mason City, IA 50401 Phone: 641-243-4593
Alex Scott Farrell, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-7234 Fax: 641-428-6373
Tara Eisenlohr, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 1st St Nw Ste 200, Mason City, IA 50401 Phone: 641-423-5044 Fax: 641-423-0994
Brooke Stewart, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1631 4th St Sw, Suite 114b, Mason City, IA 50401 Phone: 641-428-6000 Fax: 641-428-6007

Jennifer Ann Nelsen, - Medicare Nurse Practitioner in Mason City, IA

Contact Information

Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Entry inhibitors can provide first new hepatitis B & D treatments for many years

Younger, older patients report more pain and less activity following total knee replacement surgery

Automated patient registration process reduces waiting times, routine administrative tasks

Boehringer Ingelheim begins SENSCIS study to investigate safety, efficacy of nintedanib in patients with SSc-ILD

Sunitinib may be associated with cardiac toxicity

Entry inhibitors can provide first new hepatitis B & D treatments for many years

Younger, older patients report more pain and less activity following total knee replacement surgery

Automated patient registration process reduces waiting times, routine administrative tasks

Boehringer Ingelheim begins SENSCIS study to investigate safety, efficacy of nintedanib in patients with SSc-ILD

Sunitinib may be associated with cardiac toxicity

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Entry inhibitors can provide first new hepatitis B & D treatments for many years

Younger, older patients report more pain and less activity following total knee replacement surgery

Automated patient registration process reduces waiting times, routine administrative tasks

Boehringer Ingelheim begins SENSCIS study to investigate safety, efficacy of nintedanib in patients with SSc-ILD

Sunitinib may be associated with cardiac toxicity

Nurse Practitioner Nurses in Mason City, IA